Payment overview · 2025
General Payments
$147.24
6 reported records · 5 companies
Healthcare provider profile · identity verified
Harold Hsu, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · ROSEMEAD, CA · NPI 1770508111
Verified facts
What the public records show
CMS Open Payments records show Harold Hsu, M.D. received $147.24 in general payments during 2025 across 6 reported records.
Novo Nordisk Inc accounted for 30.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance, Ozempic, Rybelsus, Trelegy Ellipta.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 39 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 271 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 83 claims for Lumigan by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 526 claims for Jardiance by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Arexvy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Shingrix by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 103 claims for Trelegy Ellipta by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 526 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 46 claims for Trulicity by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 98 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 153 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $45.57 | 30.9% | 2 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $28.50 | 19.4% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $27.86 | 18.9% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $25.44 | 17.3% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $19.87 | 13.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $118.74 | 5 |
| Education | $28.50 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $45.57 | 2 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $28.50 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $27.86 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $25.44 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $24.02 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $19.87 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 526 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 98 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 153 | exact normalized | Medicare Part D |
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 103 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
39 | 13 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
271 | 70 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
83 | 12 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
526 | 67 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | AREXVY open payments reported associated product |
CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445 |
Arexvy · 2024 Exact normalized brand match · 1 Part D row |
16 | 16 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | SHINGRIX open payments reported associated product |
CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452 |
Shingrix · 2024 Exact normalized brand match · 1 Part D row |
27 | 17 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
103 | 29 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
526 | 67 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
46 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
98 | 18 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
153 | 27 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 3261 | 402 |
| Amlodipine Besylate | Amlodipine Besylate | 2115 | 268 |
| Telmisartan | Telmisartan | 1387 | 191 |
| Omeprazole | Omeprazole | 1265 | 160 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 1171 | 135 |
| Metoprolol Succinate | Metoprolol Succinate | 1038 | 128 |
| Gabapentin | Gabapentin | 941 | 150 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 941 | 120 |
| Celecoxib | Celecoxib | 856 | 139 |
| Farxiga | Dapagliflozin Propanediol | 849 | 108 |
| Finasteride | Finasteride | 819 | 101 |
| Fluocinonide | Fluocinonide | 775 | 199 |
| Losartan Potassium | Losartan Potassium | 772 | 114 |
| Ibandronate Sodium | Ibandronate Sodium | 751 | 128 |
| Meloxicam | Meloxicam | 727 | 135 |
| Montelukast Sodium | Montelukast Sodium | 722 | 86 |
| Ezetimibe | Ezetimibe | 690 | 83 |
| Metformin Hcl | Metformin Hcl | 680 | 94 |
| Tamsulosin Hcl | Tamsulosin Hcl | 675 | 91 |
| Cyclosporine | Cyclosporine | 672 | 95 |
| Levothyroxine Sodium | Levothyroxine Sodium | 636 | 71 |
| Famotidine | Famotidine | 623 | 109 |
| Bepotastine Besilate | Bepotastine Besilate | 618 | 98 |
| Pantoprazole Sodium | Pantoprazole Sodium | 594 | 129 |
| Raloxifene Hcl | Raloxifene Hcl | 541 | 62 |
| Jardiance | Empagliflozin | 526 | 67 |
| Lubiprostone | Lubiprostone | 501 | 75 |
| Clopidogrel | Clopidogrel Bisulfate | 484 | 62 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 481 | 113 |
| Baclofen | Baclofen | 455 | 64 |
| Azelastine Hcl | Azelastine Hcl | 431 | 79 |
| Tacrolimus | Tacrolimus | 419 | 85 |
| Mometasone Furoate | Mometasone Furoate | 414 | 71 |
| Risedronate Sodium | Risedronate Sodium | 413 | 45 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 407 | 47 |
| Icosapent Ethyl | Icosapent Ethyl | 403 | 67 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 394 | 87 |
| Allopurinol | Allopurinol | 377 | 54 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 372 | 63 |
| Tradjenta | Linagliptin | 363 | 44 |
| Januvia | Sitagliptin Phosphate | 360 | 41 |
| Vascepa | Icosapent Ethyl | 329 | 49 |
| Alendronate Sodium | Alendronate Sodium | 321 | 50 |
| Ketoconazole | Ketoconazole | 316 | 60 |
| Lansoprazole | Lansoprazole | 306 | 37 |
| Trazodone Hcl | Trazodone Hcl | 305 | 47 |
| Alcohol Pads | Alcohol Antiseptic Pads | 297 | 80 |
| Hydrocortisone | Hydrocortisone | 292 | 46 |
| Moxifloxacin | Moxifloxacin Hcl | 289 | 63 |
| Linzess | Linaclotide | 271 | 70 |
| Fenofibrate | Fenofibrate,micronized | 260 | 36 |
| Pregabalin | Pregabalin | 258 | 42 |
| Fluocinonide-E | Fluocinonide/Emollient Base | 256 | 70 |
| Duloxetine Hcl | Duloxetine Hcl | 253 | 42 |
| Donepezil Hcl | Donepezil Hcl | 250 | 35 |
| Mirtazapine | Mirtazapine | 223 | 37 |
| Ibuprofen | Ibuprofen | 212 | 47 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 212 | 35 |
| Amoxicillin | Amoxicillin | 210 | 109 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 210 | 40 |
| Pitavastatin Calcium | Pitavastatin Calcium | 206 | 32 |
| Xarelto | Rivaroxaban | 206 | 26 |
| Lisinopril | Lisinopril | 199 | 27 |
| Quetiapine Fumarate | Quetiapine Fumarate | 194 | 31 |
| Sildenafil Citrate | Sildenafil Citrate | 190 | 26 |
| Eliquis | Apixaban | 186 | 29 |
| Furosemide | Furosemide | 186 | 33 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 185 | 29 |
| Naproxen | Naproxen | 184 | 41 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 177 | 32 |
| Restasis | Cyclosporine | 176 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 164 | 24 |
| Lorazepam | Lorazepam | 162 | 21 |
| Mupirocin | Mupirocin | 162 | 33 |
| Epinastine Hcl | Epinastine Hcl | 159 | 42 |
| Metformin Hcl Er | Metformin Hcl | 159 | 21 |
| Calcitriol | Calcitriol | 157 | 19 |
| Ammonium Lactate | Ammonium Lactate | 154 | 43 |
| Zolpidem Tartrate | Zolpidem Tartrate | 154 | 23 |
| Rybelsus | Semaglutide | 153 | 27 |
| Glyxambi | Empagliflozin/Linagliptin | 151 | 24 |
| Dexlansoprazole Dr | Dexlansoprazole | 150 | 27 |
| Potassium Chloride | Potassium Chloride | 150 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 149 | 31 |
| Atenolol | Atenolol | 148 | 24 |
| Irbesartan | Irbesartan | 148 | 14 |
| Candesartan Cilexetil | Candesartan Cilexetil | 147 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 146 | 20 |
| Sertraline Hcl | Sertraline Hcl | 145 | 20 |
| Benazepril Hcl | Benazepril Hcl | 141 | 16 |
| Livalo | Pitavastatin Calcium | 138 | 16 |
| Fluconazole | Fluconazole | 136 | 32 |
| Lactulose | Lactulose | 132 | 21 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 128 | 28 |
| Nebivolol Hcl | Nebivolol Hcl | 128 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 125 | 15 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 123 | 16 |
| Ciclopirox | Ciclopirox | 122 | 21 |
| Carvedilol | Carvedilol | 121 | 18 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 116 | 23 |
| Paroxetine Hcl | Paroxetine Hcl | 116 | 17 |
| Tramadol Hcl | Tramadol Hcl | 115 | 18 |
| Ciprofloxacin-Dexamethasone | Ciprofloxacin Hcl/Dexameth | 113 | 30 |
| Hydrochlorothiazide | Hydrochlorothiazide | 113 | 20 |
| Ursodiol | Ursodiol | 109 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 108 | 41 |
| Prednisone | Prednisone | 106 | 48 |
| Nortriptyline Hcl | Nortriptyline Hcl | 105 | 12 |
| Pure Comfort Alcohol Pad | Alcohol Antiseptic Pads | 104 | 30 |
| Sotalol | Sotalol Hcl | 104 | 14 |
| Desloratadine | Desloratadine | 103 | 16 |
| Metoprolol Tartrate | Metoprolol Tartrate | 103 | 18 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 103 | 29 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 99 | 15 |
| Myrbetriq | Mirabegron | 98 | 17 |
| Ozempic | Semaglutide | 98 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 97 | 16 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 95 | 27 |
| Dutasteride | Dutasteride | 94 | 14 |
| Dapagliflozin | Dapagliflozin Propanediol | 90 | 65 |
| Azithromycin | Azithromycin | 88 | 63 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 87 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 86 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 84 | 21 |
| Glimepiride | Glimepiride | 84 | 12 |
| Lumigan | Bimatoprost | 83 | 12 |
| Nifedipine Er | Nifedipine | 83 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 79 | suppressed |
| Loperamide | Loperamide Hcl | 78 | 23 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 77 | suppressed |
| Nitroglycerin | Nitroglycerin | 77 | 23 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 75 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 74 | 13 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 73 | 11 |
| Ciclopirox | Ciclopirox Olamine | 71 | 14 |
| Olanzapine | Olanzapine | 68 | 14 |
| Zenpep | Lipase/Protease/Amylase | 68 | 15 |
| Meclizine Hcl | Meclizine Hcl | 66 | 20 |
| Pimecrolimus | Pimecrolimus | 65 | 22 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 64 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 61 | 11 |
| Vemlidy | Tenofovir Alafenamide | 61 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 60 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 56 | 56 |
| Methimazole | Methimazole | 56 | suppressed |
| Clonazepam | Clonazepam | 54 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 53 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 53 | 18 |
| Fenofibrate | Fenofibrate | 53 | suppressed |
| Entecavir | Entecavir | 52 | suppressed |
| Simvastatin | Simvastatin | 52 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 50 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 49 | suppressed |
| Temazepam | Temazepam | 49 | suppressed |
| Erythromycin | Erythromycin Base | 48 | suppressed |
| Valsartan | Valsartan | 48 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 47 | suppressed |
| Alprazolam | Alprazolam | 46 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 46 | suppressed |
| Levofloxacin | Levofloxacin | 46 | 37 |
| Trulicity | Dulaglutide | 46 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 44 | suppressed |
| Digoxin | Digoxin | 43 | suppressed |
| Levetiracetam | Levetiracetam | 40 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 40 | suppressed |
| Creon | Lipase/Protease/Amylase | 39 | 13 |
| Niacin Er | Niacin | 39 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 39 | 14 |
| Probenecid | Probenecid | 38 | suppressed |
| Roflumilast | Roflumilast | 38 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 37 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 37 | suppressed |
| Spironolactone | Spironolactone | 37 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 36 | suppressed |
| Prolia | Denosumab | 36 | 27 |
| Ranolazine Er | Ranolazine | 36 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 34 | 12 |
| Metronidazole | Metronidazole | 34 | suppressed |
| Pentoxifylline | Pentoxifylline | 34 | suppressed |
| Repaglinide | Repaglinide | 34 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 34 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 33 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 32 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 32 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 31 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 31 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 30 | 11 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 30 | suppressed |
| Timolol Maleate | Timolol Maleate | 30 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 29 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 29 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 29 | suppressed |
| Fluocinolone Acetonide Oil | Fluocinolone Acetonide Oil | 29 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 29 | suppressed |
| Lidocaine | Lidocaine | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | 18 |
| True Comfort Safety Pen Needle | Pen Needle, Diabetic, Safety | 29 | 11 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 28 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 28 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 28 | suppressed |
| Proctozone-Hc | Hydrocortisone | 28 | 21 |
| Solifenacin Succinate | Solifenacin Succinate | 28 | suppressed |
| Cilostazol | Cilostazol | 27 | suppressed |
| Procto-Med Hc | Hydrocortisone | 27 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 27 | 17 |
| Brimonidine Tartrate | Brimonidine Tartrate | 26 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 26 | suppressed |
| Insulin Aspart Prot Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 26 | suppressed |
| Lovastatin | Lovastatin | 26 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 25 | suppressed |
| Gemtesa | Vibegron | 25 | suppressed |
| Verapamil Er | Verapamil Hcl | 25 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Desonide | Desonide | 23 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 23 | suppressed |
| Risedronate Sodium Dr | Risedronate Sodium | 23 | suppressed |
| Dexamethasone | Dexamethasone | 22 | suppressed |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Febuxostat | Febuxostat | 22 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 21 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 21 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Clonidine | Clonidine | 20 | suppressed |
| Latanoprost | Latanoprost | 20 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 20 | suppressed |
| Scopolamine | Scopolamine | 20 | suppressed |
| Xiidra | Lifitegrast | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 16 |
| Folic Acid | Folic Acid | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Aripiprazole | Aripiprazole | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Terconazole | Terconazole | 18 | suppressed |
| Cephalexin | Cephalexin | 17 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 11 |
| Hydrocortisone Valerate | Hydrocortisone Valerate | 17 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 17 | suppressed |
| Nystop | Nystatin | 17 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 16 | 16 |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 16 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Triazolam | Triazolam | 16 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 15 | suppressed |
| Desoximetasone | Desoximetasone | 15 | suppressed |
| Diflorasone Diacetate | Diflorasone Diacetate | 15 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Travoprost | Travoprost | 15 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 15 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 15 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 14 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 14 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 13 | suppressed |
| Crestor | Rosuvastatin Calcium | 13 | suppressed |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Famciclovir | Famciclovir | 13 | suppressed |
| Gatifloxacin | Gatifloxacin | 13 | suppressed |
| Glyburide | Glyburide | 13 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 13 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 13 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 13 | suppressed |
| Alclometasone Dipropionate | Alclometasone Dipropionate | 12 | suppressed |
| Constulose | Lactulose | 12 | suppressed |
| Darifenacin Er | Darifenacin Hydrobromide | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 12 | suppressed |
| Indomethacin | Indomethacin | 12 | suppressed |
| Loteprednol Etabonate | Loteprednol Etabonate | 12 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Rytary | Carbidopa/Levodopa | 12 | suppressed |
| Silodosin | Silodosin | 12 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 12 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 11 | suppressed |
| Benzonatate | Benzonatate | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Enulose | Lactulose | 11 | 11 |
| Fentanyl | Fentanyl | 11 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 11 | 11 |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Kerendia | Finerenone | 11 | suppressed |
| Rhopressa | Netarsudil Mesylate | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $147.24 · 6 records | Novo Nordisk Inc | JARDIANCE, MOUNJARO, Ozempic, Rybelsus, TRELEGY ELLIPTA, VRAYLAR | 11 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Jardiance play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error